PBH

NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Dollar change -1.04
Percentage change -1.34	%

Peers: JNJ PG CHD CLX REYN EL CL KMB MO TSN

| Held by: IJR VTI VB IWM VBR VXF SPSM IWN VTWO IJT

Scroll to Statements

Index	RUT	P/E	17.85	EPS (ttm)	4.29	Insider Own	1.31%	Shs Outstand	49.51M	Perf Week	-4.35%
Market Cap	3.77B	Forward P/E	15.23	EPS next Y	5.02	Insider Trans	-2.87%	Shs Float	48.59M	Perf Month	-11.70%
Enterprise Value	4.71B	PEG	3.78	EPS next Q	1.00	Inst Own	106.14%	Short Float	3.43%	Perf Quarter	-8.04%
Income	214.60M	P/S	3.31	EPS this Y	5.51%	Inst Trans	-1.46%	Short Ratio	4.55	Perf Half Y	3.63%
Sales	1.14B	P/B	2.06	EPS next Y	5.34%	ROA	6.30%	Short Interest	1.66M	Perf YTD	-2.04%
Book/sh	37.06	P/C	38.48	EPS next 5Y	4.72%	ROE	12.30%	52W High	90.04 -15.04%	Perf Year	12.09%
Cash/sh	1.99	P/FCF	15.48	EPS past 3/5Y	1.99% 9.02%	ROIC	7.48%	52W Low	64.94 17.80%	Perf 3Y	26.95%
Dividend Est.	-	EV/EBITDA	12.42	Sales past 3/5Y	1.54% 3.39%	Gross Margin	53.89%	Volatility	1.83% 1.91%	Perf 5Y	110.86%
Dividend TTM	-	EV/Sales	4.14	EPS Y/Y TTM	2.65%	Oper. Margin	30.70%	ATR (14)	1.61	Perf 10Y	65.19%
Dividend Ex-Date	Dec 27, 2013	Quick Ratio	2.82	Sales Y/Y TTM	1.10%	Profit Margin	18.86%	RSI (14)	24.14	Recom	2.17
Dividend Gr. 3/5Y	- -	Current Ratio	4.20	EPS Q/Q	1.85%	SMA20	-5.97%	Beta	0.44	Target Price	93.25
Payout	0.00%	Debt/Eq	0.57	Sales Q/Q	7.05%	SMA50	-8.61%	Rel Volume	1.39	Prev Close	77.54
Employees	600	LT Debt/Eq	0.56	Earnings	May 08 BMO	SMA200	-5.18%	Avg Volume	365.57K	Price	76.50
IPO	Feb 10, 2005	Option/Short	Yes / Yes	EPS/Sales Surpr.	1.66% 2.41%	Trades		Volume	507,395	Change	-1.34%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-09-24	Downgrade	Sidoti	Buy → Neutral	$90
Jun-21-24	Upgrade	DA Davidson	Neutral → Buy	$65 → $93
Nov-17-22	Initiated	Canaccord Genuity	Buy	$71
May-10-22	Upgrade	Jefferies	Hold → Buy	$65 → $70
May-09-22	Upgrade	Oppenheimer	Perform → Outperform	$63
Aug-07-20	Downgrade	DA Davidson	Buy → Neutral
Jun-29-20	Upgrade	Sidoti	Neutral → Buy
Apr-14-20	Downgrade	Jefferies	Buy → Hold
Apr-07-20	Resumed	Sidoti	Neutral	$46
Mar-26-20	Upgrade	Jefferies	Hold → Buy	$43
Mar-24-20	Initiated	Oppenheimer	Perform
Mar-19-20	Upgrade	DA Davidson	Neutral → Buy
Jan-15-19	Downgrade	Raymond James	Outperform → Mkt Perform
Dec-04-17	Upgrade	William Blair	Mkt Perform → Outperform
Jun-02-17	Upgrade	Jefferies	Underperform → Hold
May-22-17	Upgrade	Raymond James	Mkt Perform → Outperform
Dec-27-16	Reiterated	B. Riley & Co.	Buy	$70 → $77
Nov-17-16	Initiated	Gabelli & Co	Buy	$65
Aug-12-16	Upgrade	Sidoti	Neutral → Buy
Mar-08-16	Initiated	KeyBanc Capital Mkts	Overweight	$60

Show Previous Ratings

Jul-11-25 04:21AM	Functional Dyspepsia Market Analysis and Forecast, 2025-2035, Competitive Analysis of AstraZeneca, P&G, Takeda, Prestige Consumer Healthcare, Kenvue Brands, Dr. Reddy's, Pfizer, ZERIA, Daewoong (GlobeNewswire)
Jun-30-25 09:40AM	Why Prestige Consumer Healthcare (PBH) is a Top Value Stock for the Long-Term (Zacks)
Jun-25-25 08:13PM	Analyst Report: Prestige Consumer Healthcare Inc. (Morningstar Research)
Jun-17-25 05:38PM	Medtech Products Inc. Issues Nationwide Recall of Little Remedies Honey Cough Syrup Due to Microbial Contamination (GlobeNewswire)
Jun-13-25 11:21AM	Thermo Fisher Stock Hurt by Macroeconomic Woes, Tough Competition (Zacks)
08:27AM	Loading…
08:27AM	Here's Why You Should Retain AMED Stock in Your Portfolio for Now (Zacks)
Jun-11-25 09:51AM	Here's Why You Should Retain PODD Stock in Your Portfolio Now (Zacks)
08:35AM	Should You Continue to Hold Prestige Consumer Stock in Your Portfolio? (Zacks)
Jun-09-25 04:30PM	Prestige Consumer Healthcare Inc. to Present at the Oppenheimer Annual Consumer Growth and E-Commerce Conference (GlobeNewswire)
08:37AM	PEN Stock Rises Following the Launch of Ruby XL System (Zacks)
Jun-06-25 09:02AM	Is it Apt to Retain Omnicell Stock in Your Portfolio Now? (Zacks)
Jun-03-25 10:09AM	TMO Launches Next-Generation Mass Spectrometers: Stock to Gain? (Zacks)
09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Jun-02-25 10:23AM	Here's Why You Should Retain ICLR Stock in Your Portfolio Now (Zacks)
10:18AM	LH Stock Rises Following the Expansion of Precision Oncology Portfolio (Zacks)
09:50AM	Loading…
09:50AM	Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
May-30-25 11:40AM	PBH vs. SYK: Which Stock Is the Better Value Option? (Zacks)
10:09AM	Abbott Benefits From Libre & Biosimilars Amid FX, Cost Headwinds (Zacks)
09:27AM	Illumina Introduces a New AI algorithm PromoterAI: Stock to Gain? (Zacks)
08:16AM	Thermo Fisher Launches New Spectral Flow Cytometer: Stock to Gain? (Zacks)
May-29-25 08:54AM	Bruker Stock to Gain From the Launch of MOVE-T Liquid Dairy Analyzer (Zacks)
08:47AM	Is Bio-Techne Stock the Right Pick for Your Portfolio Now? (Zacks)
May-28-25 08:12AM	Illumina's TSO Comprehensive Earns Japan's Approval: Stock to Gain? (Zacks)
May-27-25 08:15AM	Prestige Consumer Gains 35.7% in a Year: What's Driving the Stock? (Zacks)
May-26-25 08:38AM	TMO Stock Set to Gain From the Launch of New Narcotic Analyzers (Zacks)
08:30AM	Should You Retain Henry Schein Stock in Your Portfolio Right Now? (Zacks)
08:30AM	Insulet Gains 78.5% in a Year: What's Driving the Stock? (Zacks)
May-23-25 08:53AM	Edwards' New Late-Breaking Data on Severe AS Expected to Boost Stock (Zacks)
May-22-25 06:46AM	Penumbra Rallies 35.9% in a Year: What's Driving the Stock? (Zacks)
06:38AM	Should Tandem Diabetes Stock Stay in Your Portfolio Now? (Zacks)
11:36AM	Loading…
May-21-25 11:36AM	AST Business Growth & Strategic Acquisitions Support STERIS Stock (Zacks)
07:49AM	What's Driving Quest Diagnostics Stock's 25.6% Rally in a Year? (Zacks)
May-20-25 08:53AM	Should You Continue to Hold Charles River Stock in Your Portfolio? (Zacks)
08:49AM	Illumina Stock to Gain From the Launch of New DRAGEN v4.4 Software (Zacks)
May-15-25 07:01PM	Analyst Report: Prestige Consumer Healthcare Inc. (Morningstar Research)
May-14-25 11:40AM	PBH vs. ESLOY: Which Stock Should Value Investors Buy Now? (Zacks)
May-13-25 09:41AM	Prestige Consumer Stock Up 8% Since Q4 Earnings Beat, Margin Increase (Zacks)
May-09-25 03:17AM	Prestige Consumer Healthcare Inc (PBH) Q4 2025 Earnings Call Highlights: Record Revenue and ... (GuruFocus.com)
May-08-25 02:55PM	Analyst Report: Prestige Consumer Healthcare Inc. (Morningstar Research) +6.92%
09:30AM	Prestige Consumer Healthcare (PBH) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
07:20AM	Prestige Consumer Healthcare (PBH) Tops Q4 Earnings and Revenue Estimates (Zacks)
07:09AM	UPDATED: Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings (GlobeNewswire)
06:00AM	Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings (GlobeNewswire)
May-07-25 09:46AM	Prestige Consumer Healthcare Inc (PBH) Q4 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
09:15AM	Insights Into Prestige Consumer Healthcare (PBH) Q4: Wall Street Projections for Key Metrics (Zacks)
May-01-25 10:01AM	Prestige Consumer Healthcare (PBH) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Apr-30-25 07:30AM	GE HealthCare Technologies (GEHC) Q1 Earnings and Revenues Top Estimates (Zacks)
Apr-28-25 01:26PM	EMEA Growth & Product Launches to Support Boston Scientific Stock (Zacks)
11:40AM	PBH or ABT: Which Is the Better Value Stock Right Now? (Zacks)
Apr-17-25 09:52AM	3 Undervalued Medical Device Stocks to Buy in 2025 Amid Tariff Woes (Zacks)
Apr-10-25 05:00PM	Prestige Consumer Healthcare to Release Fiscal 2025 Fourth Quarter and Year-End Earnings Results (GlobeNewswire)
11:40AM	PBH vs. SYK: Which Stock Is the Better Value Option? (Zacks)
Apr-08-25 07:05PM	Analyst Report: Prestige Consumer Healthcare Inc. (Morningstar Research)
Apr-03-25 11:47AM	Walmart, Costco Are Consumer Stocks to Consider After Trump Tariffs, Oppenheimer Says (Investopedia)
Mar-31-25 04:03PM	Impax Small Cap Fund Q4 2024 Commentary (Seeking Alpha)
Mar-27-25 09:07AM	Prestige Consumer Gains 17.1% in a Year: What's Driving the Stock? (Zacks)
Mar-25-25 08:11AM	Should You Consider Retaining PBH Stock in Your Portfolio Now? (Zacks)
Feb-07-25 02:11AM	Prestige Consumer Healthcare Inc (PBH) Q3 2025 Earnings Call Highlights: Record EPS and ... (GuruFocus.com)
Feb-06-25 03:53PM	Analyst Report: Prestige Consumer Healthcare Inc. (Morningstar Research) +14.78%
06:00AM	Prestige Consumer Healthcare Inc. Reports Record Third Quarter Results and Raises Full-Year Earnings Outlook (GlobeNewswire)
Feb-05-25 07:07AM	Prestige Consumer Healthcare Inc (PBH) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Jan-21-25 07:12PM	Analyst Report: Prestige Consumer Healthcare Inc. (Morningstar Research)
Jan-09-25 08:00AM	Prestige Consumer Healthcare Announces Fiscal 2025 Third Quarter Earnings Results Date and ICR Conference Presentation (GlobeNewswire)
Jan-06-25 07:08PM	Analyst Report: Prestige Consumer Healthcare Inc. (Morningstar Research)
08:00AM	Prestige Consumer Healthcare Inc. Expands CFO Christine Sacco's Role to Include Chief Operating Officer Responsibilities (GlobeNewswire)
Nov-11-24 12:00PM	All You Need to Know About Prestige Consumer Healthcare (PBH) Rating Upgrade to Buy (Zacks)
Nov-08-24 02:13AM	Prestige Consumer Healthcare Inc (PBH) Q2 2025 Earnings Call Highlights: Navigating Supply ... (GuruFocus.com)
Nov-07-24 11:12AM	Analyst Report: Prestige Consumer Healthcare Inc. (Morningstar Research)
06:00AM	Prestige Consumer Healthcare Inc. Reports Second Quarter and First Half Fiscal 2025 Results (GlobeNewswire)
Nov-06-24 07:09PM	Analyst Report: Prestige Consumer Healthcare Inc. (Morningstar Research)
07:09AM	What To Expect From Prestige Consumer Healthcare Inc (PBH) Q2 2025 Earnings (GuruFocus.com)
Oct-11-24 08:58AM	Oppenheimer lists 5 retail stocks investors should own for 2025 (Investing.com)
Oct-09-24 05:34PM	Prestige Consumer Healthcare Inc (PBH) Q1 2025 Earnings Call Highlights: Navigating Challenges ... (GuruFocus.com)
Oct-08-24 08:00AM	Prestige Consumer Healthcare to Release Fiscal 2025 Second Quarter Earnings Results (GlobeNewswire)
Sep-20-24 08:50AM	What Makes Prestige Consumer Healthcare (PBH) a Good Fit for 'Trend Investing' (Zacks)
Sep-17-24 08:00AM	Sidoti Events, LLC's Virtual September Small-Cap Conference (ACCESSWIRE)
Sep-04-24 08:50AM	Here's Why 'Trend' Investors Would Love Betting on Prestige Consumer Healthcare (PBH) (Zacks)
Sep-03-24 08:00AM	Prestige Consumer Healthcare to Present at the Barclays Global Consumer Staples Conference (GlobeNewswire)
Aug-08-24 05:28PM	Analyst Report: Prestige Consumer Healthcare Inc. (Morningstar Research)
06:00AM	Prestige Consumer Healthcare Inc. Reports First Quarter Fiscal 2025 Results (GlobeNewswire)
Jul-02-24 04:30PM	Prestige Consumer Healthcare to Release Fiscal 2025 First Quarter Earnings Results (GlobeNewswire)
Jun-13-24 11:30AM	Prestige Consumer Healthcare (PBH) Down 0.4% Since Last Earnings Report: Can It Rebound? (Zacks)
Jun-06-24 04:30PM	Prestige Consumer Healthcare Inc. to Present at the Oppenheimer Annual Consumer Growth and E-Commerce Conference (GlobeNewswire)
May-16-24 11:36AM	Prestige Consumer (PBH) Q4 Earnings Miss, Operating Margin Falls (Zacks)
03:02AM	Prestige Consumer Healthcare Inc (PBH) (Q4 2024) Earnings Call Transcript Highlights: ... (GuruFocus.com)
May-15-24 12:19PM	Analyst Report: Prestige Consumer Healthcare Inc. (Morningstar Research) -7.01%
May-14-24 09:53PM	PBH Stock Earnings: Prestige Consumer Misses EPS, Misses Revenue for Q4 2024 (InvestorPlace)
06:15PM	Prestige Consumer Healthcare (PBH) Misses Q4 Earnings and Revenue Estimates (Zacks)
05:00PM	Prestige Consumer Healthcare Inc. Reports Fiscal Year 2024 Results (GlobeNewswire)
May-09-24 09:15AM	Unveiling Prestige Consumer Healthcare (PBH) Q4 Outlook: Wall Street Estimates for Key Metrics (Zacks)
May-06-24 06:17PM	Analyst Report: Prestige Consumer Healthcare Inc. (Morningstar Research)
Apr-25-24 10:02AM	Prestige Consumer Healthcare (PBH) Earnings Expected to Grow: What to Know Ahead of Q4 Release (Zacks)
08:30AM	Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Fourth Quarter and Year-End Earnings Results (GlobeNewswire)
Apr-19-24 07:41AM	Here's Why You Should Retain Prestige Consumer (PBH) Stock Now (Zacks)
Apr-08-24 09:40AM	Here's Why Prestige Consumer Healthcare (PBH) is a Strong Value Stock (Zacks)
Apr-03-24 11:57AM	Dramamine Celebrates its 75th Anniversary by Reviving an Unexpected Partner: The Barf Bag (GlobeNewswire)
Apr-02-24 09:06AM	Prestige Consumer (PBH) Banks on its Portfolio Amid Cost Woes (Zacks)
Mar-25-24 09:50AM	Here's Why Prestige Consumer Healthcare (PBH) is a Strong Momentum Stock (Zacks)
Mar-21-24 10:40AM	Why Prestige Consumer Healthcare (PBH) is a Top Value Stock for the Long-Term (Zacks)
Mar-05-24 12:55PM	Reasons to Retain Prestige Consumer (PBH) Stock for Now (Zacks)

Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. It operates through the North American OTC Healthcare and International OTC Healthcare segments. The North American OTC Healthcare segment consists of BC and Goody's, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Efferdent, Fleet, Gaviscon, Luden's, Monistat, Nix, Summer's Eve. The International OTC Healthcare segment includes Fess and Hydralite. The company was founded in 1996 and is headquartered in Tarrytown, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Fritz Mary Beth	SVP Quality & Regulatory	Mar 10 '25	Sale	90.00	1,678	151,020	17,157	Mar 12 04:01 PM
Fritz Mary Beth	Officer	Mar 10 '25	Proposed Sale	90.00	1,678	151,020		Mar 10 01:05 PM
Fritz Mary Beth	SVP Quality & Regulatory	Mar 03 '25	Option Exercise	44.33	6,297	279,146	25,132	Mar 05 04:01 PM
Fritz Mary Beth	SVP Quality & Regulatory	Mar 03 '25	Sale	85.39	6,297	537,701	18,835	Mar 05 04:01 PM
Fritz Mary Beth	Officer	Mar 03 '25	Proposed Sale	85.39	6,297	537,725		Mar 03 04:11 PM
Mekhail Adel	EVP, Marketing & Sales	Feb 11 '25	Option Exercise	49.53	11,083	548,935	24,048	Feb 13 04:01 PM
Mekhail Adel	EVP, Marketing & Sales	Feb 11 '25	Sale	86.55	11,083	959,271	18,365	Feb 13 04:01 PM
Mekhail Adel	Officer	Feb 11 '25	Proposed Sale	86.21	11,083	955,509		Feb 11 04:08 PM
Lombardi Ronald M.	Chief Executive Officer	Nov 19 '24	Option Exercise	56.62	10,875	615,774	326,614	Nov 21 04:01 PM
Lombardi Ronald M.	Chief Executive Officer	Nov 19 '24	Sale	82.60	10,875	898,241	320,952	Nov 21 04:01 PM
Lombardi Ronald M.	Officer	Nov 19 '24	Proposed Sale	81.58	10,875	887,187		Nov 19 04:12 PM
Lombardi Ronald M.	Chief Executive Officer	Nov 18 '24	Option Exercise	56.74	82,237	4,666,226	369,464	Nov 19 04:01 PM
Lombardi Ronald M.	Chief Executive Officer	Nov 18 '24	Sale	82.56	82,237	6,789,764	320,952	Nov 19 04:01 PM
Lombardi Ronald M.	Officer	Nov 18 '24	Proposed Sale	81.76	82,237	6,723,553		Nov 18 05:15 PM
P'Pool William	See Remarks	Nov 12 '24	Sale	81.85	8,987	735,586	20,058	Nov 14 07:42 PM
Sacco Christine	Chief Financial Officer	Nov 12 '24	Option Exercise	30.56	24,686	754,404	54,809	Nov 14 07:42 PM
Sacco Christine	Chief Financial Officer	Nov 12 '24	Sale	82.01	24,686	2,024,499	30,123	Nov 14 07:42 PM
Mekhail Adel	EVP, Marketing & Sales	Nov 12 '24	Option Exercise	44.33	5,565	246,696	27,428	Nov 14 07:41 PM
Mekhail Adel	EVP, Marketing & Sales	Nov 12 '24	Sale	82.00	9,063	743,166	18,365	Nov 14 07:41 PM
Fritz Mary Beth	SVP Quality & Regulatory	Nov 12 '24	Sale	81.97	9,885	810,266	18,835	Nov 14 07:39 PM
P'Pool William	Officer	Nov 12 '24	Proposed Sale	81.85	8,987	735,612		Nov 12 04:07 PM
Sacco Christine	Officer	Nov 12 '24	Proposed Sale	82.01	24,686	2,024,538		Nov 12 02:35 PM
Fritz Mary Beth	Officer	Nov 12 '24	Proposed Sale	81.97	9,885	810,300		Nov 12 02:29 PM
Mekhail Adel	Officer	Nov 12 '24	Proposed Sale	82.00	9,063	743,135		Nov 12 02:11 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Prestige Consumer Healthcare Inc

Upgrade your FINVIZ experience